Options
Clinical and biochemical footprints of inherited metabolic disease. XVI. Hematological abnormalities
Author(s)
Date Issued
2023-12
Date Available
2025-03-25T15:14:21Z
Abstract
Many classical inherited metabolic diseases (IMDs) are associated with significant hematological complications such as anemia or thrombosis. While these may not be the prominent presenting feature of these conditions, management of these issues is important for optimal outcomes in people with IMDs. Some disorders that are included in the nosology of inherited metabolic disorders, such as inherited disorders of red cell energy metabolism, have purely hematological features, and have typically been cared for by a hematologist. In the 16th issue of the Footprints series, we identified 265 IMDs associated with hematological abnormalities. We review the major hematological manifestations of IMDs, suggest further investigation of hematological findings, and discuss treatment options available for specific hematological complications of IMDs.
Other Sponsorship
Nenad Blau IEMbase Endowment Fund of the MCF, Marin County, CA, USA
Intramural Research Program of the National Human Genome Research Institute, Bethesda, USA
Type of Material
Journal Article
Publisher
Elsevier
Journal
Molecular Genetics and Metabolism
Volume
140
Issue
4
Start Page
1
End Page
13
Copyright (Published Version)
2023 The Authors
Language
English
Status of Item
Peer reviewed
ISSN
1096-7192
This item is made available under a Creative Commons License
File(s)
Loading...
Name
1-s2.0-S1096719223003657-main.pdf
Size
3.02 MB
Format
Adobe PDF
Checksum (MD5)
276cc348f3900201df1c4bad8c6db501
Owning collection